BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9509891)

  • 1. The structure and signalling properties of 5-HT receptors: an endless diversity?
    Martin GR; Eglen RM; Hamblin MW; Hoyer D; Yocca F
    Trends Pharmacol Sci; 1998 Jan; 19(1):2-4. PubMed ID: 9509891
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
    Newman-Tancredi A; Cussac D; Marini L; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Models of 5-hydroxytryptamine receptors. A review.
    Chilmonczyk Z
    J Pharm Pharmacol; 1995 Oct; 47(10):791-801. PubMed ID: 8583345
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular modelling of the 5-hydroxytryptamine receptors.
    Wishart G; Bremner DH; Sturrock KR
    Recept Channels; 1999; 6(4):317-35. PubMed ID: 10412724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT2 receptor subtypes: a family re-united?
    Baxter G; Kennett G; Blaney F; Blackburn T
    Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 5-HT7 receptor: orphan found.
    Eglen RM; Jasper JR; Chang DJ; Martin GR
    Trends Pharmacol Sci; 1997 Apr; 18(4):104-7. PubMed ID: 9149537
    [No Abstract]   [Full Text] [Related]  

  • 8. Site-directed mutagenesis of the 5-HT1B receptor increases the affinity of 5-HT for the agonist low-affinity conformation and reduces the intrinsic activity of 5-HT.
    Grånäs C; Nordquist J; Mohell N; Larhammar D
    Eur J Pharmacol; 2001 Jun; 421(2):69-76. PubMed ID: 11399261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
    Bühlen M; Fink K; Böing C; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of serotonin G protein-coupled receptors.
    McCorvy JD; Roth BL
    Pharmacol Ther; 2015 Jun; 150():129-42. PubMed ID: 25601315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
    Dukat M; Choi YN; Teitler M; Du Pre A; Herrick-Davis K; Smith C; Glennon RA
    Bioorg Med Chem Lett; 2001 Jun; 11(12):1599-603. PubMed ID: 11412989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems.
    Berg KA; Clarke WP; Sailstad C; Saltzman A; Maayani S
    Mol Pharmacol; 1994 Sep; 46(3):477-84. PubMed ID: 7935328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazoles and thiopyridines: novel series of high affinity h5HT(7) ligands.
    Thomson CG; Beer MS; Curtis NR; Diggle HJ; Handford E; Kulagowski JJ
    Bioorg Med Chem Lett; 2004 Feb; 14(3):677-80. PubMed ID: 14741267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple conformations of native and recombinant human 5-hydroxytryptamine(2a) receptors are labeled by agonists and discriminated by antagonists.
    López-Giménez JF; Villazón M; Brea J; Loza MI; Palacios JM; Mengod G; Vilaró MT
    Mol Pharmacol; 2001 Oct; 60(4):690-9. PubMed ID: 11562430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand induced conformational states of the 5-HT(1A) receptor.
    Sylte I; Bronowska A; Dahl SG
    Eur J Pharmacol; 2001 Mar; 416(1-2):33-41. PubMed ID: 11282110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Centennial perspective: serotonin receptors.
    Sanders-Bush E; Airey DC
    Mol Interv; 2008 Oct; 8(5):200-3. PubMed ID: 19015382
    [No Abstract]   [Full Text] [Related]  

  • 17. (+/-) 3-Amino-6-carboxamido-1,2,3,4-tetrahydrocarbazole: a conformationally restricted analogue of 5-carboxamidotryptamine with selectivity for the serotonin 5-HT1D receptor.
    King FD; Brown AM; Gaster LM; Kaumann AJ; Medhurst AD; Parker SG; Parsons AA; Patch TL; Raval P
    J Med Chem; 1993 Jun; 36(13):1918-9. PubMed ID: 8515429
    [No Abstract]   [Full Text] [Related]  

  • 18. Targeting 5-HT receptors for the treatment of obesity.
    Sargent BJ; Henderson AJ
    Curr Opin Pharmacol; 2011 Feb; 11(1):52-8. PubMed ID: 21330209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signalling properties and pharmacology of a 5-HT7 -type serotonin receptor from Tribolium castaneum.
    Vleugels R; Lenaerts C; Vanden Broeck J; Verlinden H
    Insect Mol Biol; 2014 Apr; 23(2):230-43. PubMed ID: 24330075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular, pharmacological and functional diversity of 5-HT receptors.
    Hoyer D; Hannon JP; Martin GR
    Pharmacol Biochem Behav; 2002 Apr; 71(4):533-54. PubMed ID: 11888546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.